Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity

ClinicalTrials.gov ID: NCT04775082

Public ClinicalTrials.gov record NCT04775082. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effect and Safety of Liraglutide 3.0 mg on Weight Management in Children With Obesity Aged 6 to Below 12 Years: 56-week, Double-blind, Randomised, Placebo-controlled Trial

Study identification

NCT ID
NCT04775082
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
78 participants

Conditions and interventions

Conditions

Interventions

  • Liraglutide Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
6 Years to 12 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 3, 2021
Primary completion
Jul 31, 2023
Completion
Jan 14, 2027
Last update posted
Dec 3, 2025

2021 – 2027

United States locations

U.S. sites
9
U.S. states
9
U.S. cities
9
Facility City State ZIP Site status
TMC Hlthcr Clin Res Office Tucson Arizona 85712
Children's Hospital Colorado Denver Colorado 80045
Solaris Clinical Research Meridian Idaho 83646
Pennington Biom Res Ctr Baton Rouge Louisiana 70808
Barry J. Reiner, MD LLC Baltimore Maryland 21229
University of Minnesota_CPOM Minneapolis Minnesota 55414
UBMD Peds-Div of Endo/Diabetes Buffalo New York 14203
PriMed Clinical Research Dayton Ohio 45419
UPMC Child Hosp-Pittsburgh Pittsburgh Pennsylvania 15224

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04775082, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2025 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04775082 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →